Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

BACKGROUND: De novo steatosis is the main criteria for non-alcoholic fatty liver disease (NAFLD), which is becoming a clinically relevant comorbidity in HIV-infected patients. This may be due to the HIV virus itself, as well as long-term toxicities deriving from antiretroviral therapy. Therefore, HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Bischoff, Jenny, Gu, Wenyi, Schwarze-Zander, Carolynne, Boesecke, Christoph, Wasmuth, Jan-Christian, van Bremen, Kathrin, Dold, Leona, Rockstroh, Jürgen K, Trebicka, Jonel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427211/
https://www.ncbi.nlm.nih.gov/pubmed/34522873
http://dx.doi.org/10.1016/j.eclinm.2021.101116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427211/
https://www.ncbi.nlm.nih.gov/pubmed/34522873
http://dx.doi.org/10.1016/j.eclinm.2021.101116

Ejemplares similares